JNJ-63623872 (14C-labeled)

JNJ-63623872 · Janssen Cilag N.V./S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-63623872 (14C-labeled), covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Absorption, Metabolism and Excretion of 14C-JNJ-63623872 After a Single Dose in Healthy Male Participants [Phase 1]

See pricing